SCHEMBL7149068

SCHEMBL7149068

O=C(O)C(CCC(=O)N1CCC2(CCN(Cc3ccccc3)CC2)CC1)NS(=O)(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 9/20 0.58
ITGA2B P08514 9/20 0.58
CYP2D6 P10635 5/20 0.52
CHRM2 P08172 1/20 0.50
CHRM3 P20309 1/20 0.50
ITGAV P06756 1/20 0.49
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP3A4 P08684 2/20 0.47
USP2 O75604 1/20 0.47
MAPK1 P28482 1/20 0.47
MMP9 P14780 3/20 0.47
MMP8 P22894 2/20 0.47
MMP13 P45452 1/20 0.47
ADAMTS4 O75173 1/20 0.47
MMP2 P08253 2/20 0.47
CYP2C19 P33261 2/20 0.47
MMP12 P39900 1/20 0.47
MMP14 P50281 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144472 0.88 ITGB3 (0.62) ITGB3ITGA2BITGAVMMP9MMP8
SCHEMBL6620445 0.87 CYP2D6 (0.50) ITGB3ITGA2BCYP2D6CHRM2CHRM3
SCHEMBL6620443 0.87 CYP2D6 (0.50) ITGB3ITGA2BCYP2D6CHRM2CHRM3
SCHEMBL7147856 0.84 MMP2 (0.58) ITGB3ITGA2BITGAVMMP9MMP8
Acetic Acid SCHEMBL7153863 0.83 ITGB3 (0.64) ITGB3ITGA2BITGAVMMP9MMP8
SCHEMBL7357056 0.83 ITGB3 (0.53) ITGB3ITGA2BITGAVMMP9MMP8
Hydrochloric Acid SCHEMBL6622253 0.81 ITGB3 (0.55) ITGB3ITGA2BITGAVSMN1; SMN2MMP9
Hydrochloric Acid SCHEMBL6622243 0.81 ITGB3 (0.55) ITGB3ITGA2BITGAVMMP9MMP8
Hydrochloric Acid SCHEMBL6633329 0.81 ITGB3 (0.55) ITGB3ITGA2BITGAVMMP9MMP8
Hydrochloric Acid SCHEMBL6622249 0.81 ITGB3 (0.55) ITGB3ITGA2BITGAVSMN1; SMN2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6528534-B2 Useful as glycoprotein IIb/IIIa antagonists for prophylaxis thrombosis, therapy of atheroschlerosis, arterioschlerosis, acute myocardial infarction, chronic stable angina, unstable angina, transient ischemic attacks and strokes MILLENNIUM PHARMACEUTICALS, INC. 2003-03-04 US disclosed